Avery Products Corp., a division of CCL Industries Corp., has filed a lawsuit against sellers of alleged counterfeit Avery labels in the United States in an effort to protect the reputation of its brand.
The counterfeit suit that was filed involves the popular Avery branded consumer labels, not CCL’s pharmaceutical or other industrial labeling.
The company was able to identify the alleged counterfeit Avery products after receiving consumer complaints about defective labels purchased online. The products came boxed in what appeared to be Avery packaging, but didn’t perform like genuine Avery labels.
Consumers who suspect they might have purchased counterfeit Avery products are urged to contact the Avery Consumer Care Center at (800) 462-8379. Counterfeit products may be returned to Avery and once verified will be replaced free of charge, according to the company.
Avery Products Corp. is the world’s largest supplier of labels, specialty converted media and software solutions to enable short-run digital printing in businesses and homes alongside complementary products sold through distributors and mass market retailers under the Avery brand.
Avery brands, product names, and codes are trademarks of CCL Industries, Inc.
CCL employs more than 20,000 people operating 154 production facilities in 36 countries on six continents with corporate offices in Toronto, Canada, and Framingham, Mass. CCL Healthcare has invested more than $500 million in pharmaceutical printing plants worldwide.
(Sources: Avery Products Corp.; CCL Industries Corp.)
